Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Tyra Biosciences, Inc. (TYRA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 41,270,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Tyra Biosciences is an oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Co. is focused on developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor, or FGFR family. Co.'s lead product candidate, TYRA-300, is designed to selectively inhibit Fibroblast Growth Factor Receptor3, with an initial focus on patients with bladder cancer. In addition, Co. has pipeline development programs targeting FGFR2-related cancers, FGFR3-related achondroplasia, REarranged during Transfection kinase, and FGFR4-related cancers.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 221,691 221,691 456,290 785,314
Total Sell Value $3,766,874 $3,766,874 $7,701,881 $12,216,507
Total People Sold 2 2 2 3
Total Sell Transactions 15 15 38 53
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 135
  Page 1 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Tada Hiroomi Chief Medical Officer   •       –      –    2024-03-15 4 A $6.58 $12,947 D/D 1,968 86,435     -
   Harris Todd President and CEO   •       •      –    2024-03-15 4 A $6.58 $12,369 D/D 1,880 1,504,577     -
   Fuhrman Alan Chief Financial Officer   •       –      –    2024-03-15 4 A $12.48 $11,629 D/D 932 2,395     -
   Bensen Daniel Chief Operating Officer   •       –      –    2024-03-11 4 AS $20.00 $4,000 D/D (200) 431,683     -
   Bensen Daniel Chief Operating Officer   •       –      –    2024-03-07 4 AS $20.00 $1,360 D/D (68) 431,883     -
   Bensen Daniel Chief Operating Officer   •       –      –    2024-03-06 4 AS $20.09 $34,819 D/D (1,733) 431,951     -
   Bensen Daniel Chief Operating Officer   •       –      –    2024-03-05 4 AS $20.02 $23,802 D/D (1,189) 433,684     -
   Bensen Daniel Chief Operating Officer   •       –      –    2024-03-04 4 AS $20.08 $101,654 D/D (5,063) 434,873     -
   Bensen Daniel Chief Operating Officer   •       –      –    2024-03-01 4 AS $20.04 $58,112 D/D (2,900) 439,936     -
   Bensen Daniel Chief Operating Officer   •       –      –    2024-02-29 4 AS $20.00 $41,003 D/D (2,050) 442,836     -
   Bensen Daniel Chief Operating Officer   •       –      –    2024-02-28 4 AS $20.13 $117,729 D/D (5,849) 444,886     -
   Bensen Daniel Chief Operating Officer   •       –      –    2024-02-27 4 AS $20.00 $14,900 D/D (745) 450,735     -
   Bensen Daniel Chief Operating Officer   •       –      –    2024-02-12 4 AS $20.00 $30,020 D/D (1,501) 451,480     -
   Bensen Daniel Chief Operating Officer   •       –      –    2024-02-07 4 AS $18.09 $173,466 D/D (9,587) 452,981     -
   Shah Rajeev M. Director   –       •       •   2024-02-06 4 A $13.01 $41,373,817 I/I 3,180,155 8,477,275     -
   Davis Aaron I. See Remarks   •       •      –    2024-02-06 4 A $13.01 $824,990 I/I 63,412 85,939     -
   Bensen Daniel Chief Operating Officer   •       –      –    2024-02-06 4 AS $18.09 $278,827 D/D (15,413) 462,568     -
   Harris Todd President and CEO   •       •      –    2024-02-05 4 AS $16.97 $234,430 D/D (13,817) 1,502,697     -
   Harris Todd President and CEO   •       •      –    2024-02-02 4 AS $16.45 $1,421,655 D/D (86,183) 1,516,514     -
   Bensen Daniel Chief Operating Officer   •       –      –    2024-02-02 4 AS $16.31 $1,231,097 D/D (75,393) 477,981     -
   Bensen Daniel Chief Operating Officer   •       –      –    2024-02-02 4 OE $0.61 $15,490 D/D 25,393 553,374     -
   Harris Todd President and CEO   •       •      –    2023-09-15 4 A $6.58 $9,349 D/D 1,421 1,602,697     -
   Tada Hiroomi Chief Medical Officer   •       –      –    2023-09-15 4 A $6.58 $8,796 D/D 1,337 84,467     -
   Fuhrman Alan Chief Financial Officer   •       –      –    2023-09-15 4 A $12.50 $18,293 D/D 1,463 1,463     -
   Bensen Daniel Chief Operating Officer   •       –      –    2023-07-21 4 AS $16.01 $62,428 D/D (3,900) 527,981     -
  135 Records found
  1  2  3  4  5  6   
  Page 1 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us